PLA2G3 and cancer: Our present results suggest that colorectal sPLA2-III drives another arm of the lipid pathways, namely the production of pro-inflammatory/pro-tumorigenic lysophosholipids, which may be eventually linked to the exacerbation of colonic inflammation and cancer.